Select for export The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211064720 PubMed 35090363 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-03 Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J Europe PMC Published psilocybin DepressionReceptor PharmacologyEmotional Processing Randomized Controlled Trial More
Select for export Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviour No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100764 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 E. Stojek, Jack Prenderville, F. Dunphy-Doherty OpenAlex Published psilocybin Anxiety Other More
Select for export Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100407 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, Albert Adell, J. Javier Meana, J.E. Ortega OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100213 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100511 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt OpenAlex Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Selling the Priceless Mushroom: A History of Psilocybin Mushroom Trade in the Sierra Mazateca (Oaxaca) Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31389/jied.101 Copy citation Copy BibTeX Journal of Illicit Economies and Development 2021-12-31 Marcos Garcia de Teresa OpenAlex Published psilocybin General Other More
Select for export An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245221124117 Copy citation Copy BibTeX Drug Science Policy and Law 2021-12-31 F. N. Smith, Joanna C. Neill, Verity Wainwright OpenAlex Published psilocybin Clinical TrialVeteransSafety Clinical Trial More
Select for export The economics of psychedelic-assisted therapies: A research agenda. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1025726 PubMed 36545038 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Marseille E, Bertozzi S, Kahn JG PubMed Published psilocybin DepressionPTSDAddiction Other More
Select for export Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.32996/jmhs.2021.2.2.18 Copy citation Copy BibTeX Journal of Medical and Health Studies 2021-12-30 Victor Chiruta, Paulina K Zemla, Pixie Miller, Nicola Santarossa, John A Hannan OpenAlex Published psilocybin SafetyToxicity Other More
Select for export Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/fbp.0000000000000662 PubMed 35007231 Copy citation Copy BibTeX Behavioural Pharmacology 2021-12-12 Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.394 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle OpenAlex Published psilocybin DepressionConsciousnessSafety Other More
Select for export P.0298 Evaluation of the acute mechanism of action of psilocybin in mice No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.282 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, J. Javier Meana, Jorge E. Ortega OpenAlex Published psilocybin Mechanism of ActionOxidative StressAnimal Study Animal Study More
Select for export Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/21655979.2021.1987090 PubMed 34607532 Copy citation Copy BibTeX Bioengineered 2021-11-30 Gibbons WJ, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmjopen-2021-056091 PubMed 34853114 Copy citation Copy BibTeX BMJ Open 2021-11-30 Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G Europe PMC Published psilocybin DepressionBrain ImagingBiomarkers Randomized Controlled Trial More
Select for export Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ph14121213 PubMed 34959614 Copy citation Copy BibTeX Unknown journal 2021-11-23 Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J Europe PMC Published psilocybin NeuroplasticityMechanism of ActionReceptor Pharmacology Review Article More
Select for export Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06027-y PubMed 34812901 Copy citation Copy BibTeX Unknown journal 2021-11-22 Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Systematic Review More
Select for export Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40263-021-00877-y PubMed 34791625 Copy citation Copy BibTeX Unknown journal 2021-11-16 Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB Europe PMC Published psilocybin DepressionPharmacologyMechanism of Action Review Article More
Select for export Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study". Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.735523 PubMed 34744825 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-10-19 Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC Europe PMC Published psilocybin Eating DisordersEnd-of-Life DistressNeuroplasticity Clinical Trial More
Select for export Novel antidepressant drugs: Beyond monoamine targets. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852921000791 PubMed 34588093 Copy citation Copy BibTeX Unknown journal 2021-09-29 Gonda X, Dome P, Neill JC, Tarazi FI. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.tips.2021.08.003 PubMed 34565579 Copy citation Copy BibTeX Unknown journal 2021-09-23 Aleksandrova LR, Phillips AG. Europe PMC Published psilocybin DepressionNeuroplasticityMechanism of Action Review Article More
